rs4134932
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_004722.4(AP4M1):c.1305C>T(p.Asn435Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0286 in 1,613,992 control chromosomes in the GnomAD database, including 834 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 44 hom., cov: 32)
Exomes 𝑓: 0.030 ( 790 hom. )
Consequence
AP4M1
NM_004722.4 synonymous
NM_004722.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.27
Genes affected
AP4M1 (HGNC:574): (adaptor related protein complex 4 subunit mu 1) This gene encodes a subunit of the heterotetrameric AP-4 complex. The encoded protein belongs to the adaptor complexes medium subunits family. This AP-4 complex is involved in the recognition and sorting of cargo proteins with tyrosine-based motifs from the trans-golgi network to the endosomal-lysosomal system. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 7-100106825-C-T is Benign according to our data. Variant chr7-100106825-C-T is described in ClinVar as [Benign]. Clinvar id is 128404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-100106825-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.27 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0184 (2800/152344) while in subpopulation NFE AF= 0.0299 (2031/68030). AF 95% confidence interval is 0.0288. There are 44 homozygotes in gnomad4. There are 1333 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 44 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4M1 | NM_004722.4 | c.1305C>T | p.Asn435Asn | synonymous_variant | 15/15 | ENST00000359593.9 | NP_004713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4M1 | ENST00000359593.9 | c.1305C>T | p.Asn435Asn | synonymous_variant | 15/15 | 1 | NM_004722.4 | ENSP00000352603.4 |
Frequencies
GnomAD3 genomes AF: 0.0184 AC: 2802AN: 152226Hom.: 44 Cov.: 32
GnomAD3 genomes
AF:
AC:
2802
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0191 AC: 4794AN: 251092Hom.: 77 AF XY: 0.0204 AC XY: 2776AN XY: 135830
GnomAD3 exomes
AF:
AC:
4794
AN:
251092
Hom.:
AF XY:
AC XY:
2776
AN XY:
135830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0296 AC: 43296AN: 1461648Hom.: 790 Cov.: 34 AF XY: 0.0296 AC XY: 21519AN XY: 727142
GnomAD4 exome
AF:
AC:
43296
AN:
1461648
Hom.:
Cov.:
34
AF XY:
AC XY:
21519
AN XY:
727142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0184 AC: 2800AN: 152344Hom.: 44 Cov.: 32 AF XY: 0.0179 AC XY: 1333AN XY: 74486
GnomAD4 genome
AF:
AC:
2800
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
1333
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 01, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 01, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 27, 2021 | - - |
Hereditary spastic paraplegia 50 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at